<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-12-20" modified="2019-06-05" version="136">
<accession>P0AES4</accession>
<accession>P09097</accession>
<name>GYRA_ECOLI</name>
<protein>
<recommendedName>
<fullName evidence="4">DNA gyrase subunit A</fullName>
<ecNumber evidence="4 5 13 14 16 32">5.6.2.3</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary" evidence="4">gyrA</name>
<name type="synonym">hisW</name>
<name type="synonym" evidence="36">nalA</name>
<name type="synonym">parD</name>
<name type="ordered locus">b2231</name>
<name type="ordered locus">JW2225</name>
</gene>
<organism>
<name type="scientific">Escherichia coli (strain K12)</name>
<dbReference type="NCBI Taxonomy" id="83333"/>
<lineage>
<taxon>Bacteria</taxon>
<taxon>Proteobacteria</taxon>
<taxon>Gammaproteobacteria</taxon>
<taxon>Enterobacterales</taxon>
<taxon>Enterobacteriaceae</taxon>
<taxon>Escherichia</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="J. Mol. Biol." volume="197" first="729" last="736">
<title>Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase.</title>
<authorList>
<person name="Swanberg S.L."/>
<person name="Wang J.C."/>
</authorList>
<dbReference type="PubMed" id="2828631"/>
<dbReference type="DOI" id="10.1016/0022-2836(87)90479-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Mol. Gen. Genet." volume="211" first="1" last="7">
<title>Quinolone-resistant mutations of the gyrA gene of Escherichia coli.</title>
<authorList>
<person name="Yoshida H."/>
<person name="Kojima T."/>
<person name="Yamagishi J."/>
<person name="Nakamura S."/>
</authorList>
<dbReference type="PubMed" id="2830458"/>
<dbReference type="DOI" id="10.1007/BF00338386"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<strain>K12 / KL16</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1987" name="Mol. Microbiol." volume="1" first="259" last="273">
<title>The parD- mutant of Escherichia coli also carries a gyrAam mutation. The complete sequence of gyrA.</title>
<authorList>
<person name="Hussain K."/>
<person name="Elliott E.J."/>
<person name="Salmond G.P.C."/>
</authorList>
<dbReference type="PubMed" id="2834621"/>
<dbReference type="DOI" id="10.1111/j.1365-2958.1987.tb01932.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS QUINOLONE-RESISTANTS ASN-87 AND ILE-MET-MET-ILE-798</scope>
<source>
<strain>OV6</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1989" name="Antimicrob. Agents Chemother." volume="33" first="886" last="894">
<title>Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.</title>
<authorList>
<person name="Cullen M.E."/>
<person name="Wyke A.W."/>
<person name="Kuroda R."/>
<person name="Fisher L.M."/>
</authorList>
<dbReference type="PubMed" id="2548439"/>
<dbReference type="DOI" id="10.1128/AAC.33.6.886"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS QUINOLONE-RESISTANT GLU-678 AND SER-828</scope>
<source>
<strain>227</strain>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="DNA Res." volume="4" first="91" last="113">
<title>Construction of a contiguous 874-kb sequence of the Escherichia coli-K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features.</title>
<authorList>
<person name="Yamamoto Y."/>
<person name="Aiba H."/>
<person name="Baba T."/>
<person name="Hayashi K."/>
<person name="Inada T."/>
<person name="Isono K."/>
<person name="Itoh T."/>
<person name="Kimura S."/>
<person name="Kitagawa M."/>
<person name="Makino K."/>
<person name="Miki T."/>
<person name="Mitsuhashi N."/>
<person name="Mizobuchi K."/>
<person name="Mori H."/>
<person name="Nakade S."/>
<person name="Nakamura Y."/>
<person name="Nashimoto H."/>
<person name="Oshima T."/>
<person name="Oyama S."/>
<person name="Saito N."/>
<person name="Sampei G."/>
<person name="Satoh Y."/>
<person name="Sivasundaram S."/>
<person name="Tagami H."/>
<person name="Takahashi H."/>
<person name="Takeda J."/>
<person name="Takemoto K."/>
<person name="Uehara K."/>
<person name="Wada C."/>
<person name="Yamagata S."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="9205837"/>
<dbReference type="DOI" id="10.1093/dnares/4.2.91"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Science" volume="277" first="1453" last="1462">
<title>The complete genome sequence of Escherichia coli K-12.</title>
<authorList>
<person name="Blattner F.R."/>
<person name="Plunkett G. III"/>
<person name="Bloch C.A."/>
<person name="Perna N.T."/>
<person name="Burland V."/>
<person name="Riley M."/>
<person name="Collado-Vides J."/>
<person name="Glasner J.D."/>
<person name="Rode C.K."/>
<person name="Mayhew G.F."/>
<person name="Gregor J."/>
<person name="Davis N.W."/>
<person name="Kirkpatrick H.A."/>
<person name="Goeden M.A."/>
<person name="Rose D.J."/>
<person name="Mau B."/>
<person name="Shao Y."/>
</authorList>
<dbReference type="PubMed" id="9278503"/>
<dbReference type="DOI" id="10.1126/science.277.5331.1453"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Mol. Syst. Biol." volume="2" first="E1" last="E5">
<title>Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110.</title>
<authorList>
<person name="Hayashi K."/>
<person name="Morooka N."/>
<person name="Yamamoto Y."/>
<person name="Fujita K."/>
<person name="Isono K."/>
<person name="Choi S."/>
<person name="Ohtsubo E."/>
<person name="Baba T."/>
<person name="Wanner B.L."/>
<person name="Mori H."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="16738553"/>
<dbReference type="DOI" id="10.1038/msb4100049"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1987" name="J. Bacteriol." volume="169" first="1272" last="1278">
<title>Fusions of the Escherichia coli gyrA and gyrB control regions to the galactokinase gene are inducible by coumermycin treatment.</title>
<authorList>
<person name="Menzel R."/>
<person name="Gellert M."/>
</authorList>
<dbReference type="PubMed" id="3029031"/>
<dbReference type="DOI" id="10.1128/jb.169.3.1272-1278.1987"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-88</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="5339" last="5344">
<title>Mapping the active site tyrosine of Escherichia coli DNA gyrase.</title>
<authorList>
<person name="Horowitz D.S."/>
<person name="Wang J.C."/>
</authorList>
<dbReference type="PubMed" id="3031051"/>
</citation>
<scope>PROTEIN SEQUENCE OF 17-24; 61-66 AND 123-126</scope>
<scope>FUNCTION</scope>
<scope>ACTIVE SITE</scope>
<scope>REACTION MECHANISM</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1976" name="Proc. Natl. Acad. Sci. U.S.A." volume="73" first="3872" last="3876">
<title>DNA gyrase: an enzyme that introduces superhelical turns into DNA.</title>
<authorList>
<person name="Gellert M."/>
<person name="Mizuuchi K."/>
<person name="O'Dea M.H."/>
<person name="Nash H.A."/>
</authorList>
<dbReference type="PubMed" id="186775"/>
<dbReference type="DOI" id="10.1073/pnas.73.11.3872"/>
</citation>
<scope>FUNCTION IN GENERATING NEGATIVELY SUPERCOILED DNA</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ATP-DEPENDENCE</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1977" name="Proc. Natl. Acad. Sci. U.S.A." volume="74" first="4772" last="4776">
<title>Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.</title>
<authorList>
<person name="Gellert M."/>
<person name="Mizuuchi K."/>
<person name="O'Dea M.H."/>
<person name="Itoh T."/>
<person name="Tomizawa J.I."/>
</authorList>
<dbReference type="PubMed" id="337300"/>
<dbReference type="DOI" id="10.1073/pnas.74.11.4772"/>
</citation>
<scope>FUNCTION IN RELAXING SUPERCOILED DNA</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1990" name="Antimicrob. Agents Chemother." volume="34" first="1271" last="1272">
<title>Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.</title>
<authorList>
<person name="Yoshida H."/>
<person name="Bogaki M."/>
<person name="Nakamura M."/>
<person name="Nakamura S."/>
</authorList>
<dbReference type="PubMed" id="2168148"/>
<dbReference type="DOI" id="10.1128/AAC.34.6.1271"/>
</citation>
<scope>VARIANTS QUINOLONE-RESISTANT SER-67; CYS-81; LEU-83; TRP-83; PRO-84; ASN-87 AND HIS-106</scope>
<source>
<strain>K12 / KL16</strain>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="Antimicrob. Agents Chemother." volume="35" first="387" last="389">
<title>4-quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction.</title>
<authorList>
<person name="Oram M."/>
<person name="Fisher L.M."/>
</authorList>
<dbReference type="PubMed" id="1850972"/>
<dbReference type="DOI" id="10.1128/AAC.35.2.387"/>
</citation>
<scope>VARIANTS QUINOLONE-RESISTANT LEU-83; TRP-83 AND VAL-87</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1991" name="Antimicrob. Agents Chemother." volume="35" first="335" last="340">
<title>Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins.</title>
<authorList>
<person name="Hallett P."/>
<person name="Maxwell A."/>
</authorList>
<dbReference type="PubMed" id="1850970"/>
<dbReference type="DOI" id="10.1128/AAC.35.2.335"/>
</citation>
<scope>MUTAGENESIS OF SER-83 AND GLN-106</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="1992" name="J. Mol. Biol." volume="226" first="735" last="745">
<title>Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes.</title>
<authorList>
<person name="Bernard P."/>
<person name="Couturier M."/>
</authorList>
<dbReference type="PubMed" id="1324324"/>
<dbReference type="DOI" id="10.1016/0022-2836(92)90629-X"/>
</citation>
<scope>INHIBITION BY TOXIN PROTEIN CCDB</scope>
<scope>MUTAGENESIS OF ARG-462</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1993" name="J. Mol. Biol." volume="234" first="534" last="541">
<title>The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase.</title>
<authorList>
<person name="Bernard P."/>
<person name="Kezdy K.E."/>
<person name="Van Melderen L."/>
<person name="Steyaert J."/>
<person name="Wyns L."/>
<person name="Pato M.L."/>
<person name="Higgins P.N."/>
<person name="Couturier M."/>
</authorList>
<dbReference type="PubMed" id="8254658"/>
<dbReference type="DOI" id="10.1006/jmbi.1993.1609"/>
</citation>
<scope>MUTAGENESIS OF ARG-462</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1994" name="Antimicrob. Agents Chemother." volume="38" first="1966" last="1973">
<title>Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.</title>
<authorList>
<person name="Nakada N."/>
<person name="Gmuender H."/>
<person name="Hirata T."/>
<person name="Arisawa M."/>
</authorList>
<dbReference type="PubMed" id="7811004"/>
<dbReference type="DOI" id="10.1128/AAC.38.9.1966"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1996" name="J. Mol. Biol." volume="256" first="473" last="482">
<title>Partner switching mechanisms in inactivation and rejuvenation of Escherichia coli DNA gyrase by F plasmid proteins LetD (CcdB) and LetA (CcdA).</title>
<authorList>
<person name="Maki S."/>
<person name="Takiguchi S."/>
<person name="Horiuchi T."/>
<person name="Sekimizu K."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="8604132"/>
<dbReference type="DOI" id="10.1006/jmbi.1996.0102"/>
</citation>
<scope>INHIBITION BY TOXIN PROTEIN CCDB</scope>
<scope>REJUVENATION BY CCDA</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="14416" last="14421">
<title>Conversion of DNA gyrase into a conventional type II topoisomerase.</title>
<authorList>
<person name="Kampranis S.C."/>
<person name="Maxwell A."/>
</authorList>
<dbReference type="PubMed" id="8962066"/>
<dbReference type="DOI" id="10.1073/pnas.93.25.14416"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="13302" last="13308">
<title>acrB mutation located at carboxyl-terminal region of gyrase B subunit reduces DNA binding of DNA gyrase.</title>
<authorList>
<person name="Funatsuki K."/>
<person name="Tanaka R."/>
<person name="Inagaki S."/>
<person name="Konno H."/>
<person name="Katoh K."/>
<person name="Nakamura H."/>
</authorList>
<dbReference type="PubMed" id="9148951"/>
<dbReference type="DOI" id="10.1074/jbc.272.20.13302"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBUNIT</scope>
<scope>DNA-BINDING</scope>
<source>
<strain>K12 / N2879</strain>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="1997" name="Electrophoresis" volume="18" first="1243" last="1251">
<title>Escherichia coli proteome analysis using the gene-protein database.</title>
<authorList>
<person name="VanBogelen R.A."/>
<person name="Abshire K.Z."/>
<person name="Moldover B."/>
<person name="Olson E.R."/>
<person name="Neidhardt F.C."/>
</authorList>
<dbReference type="PubMed" id="9298644"/>
<dbReference type="DOI" id="10.1002/elps.1150180805"/>
</citation>
<scope>IDENTIFICATION BY 2D-GEL</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="2580" last="2592">
<title>Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.</title>
<authorList>
<person name="Zechiedrich E.L."/>
<person name="Khodursky A.B."/>
<person name="Cozzarelli N.R."/>
</authorList>
<dbReference type="PubMed" id="9334322"/>
<dbReference type="DOI" id="10.1101/gad.11.19.2580"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1997" name="Mol. Microbiol." volume="26" first="897" last="910">
<title>Requirement of topoisomerase IV parC and parE genes for cell cycle progression and developmental regulation in Caulobacter crescentus.</title>
<authorList>
<person name="Ward D.V."/>
<person name="Newton A."/>
</authorList>
<dbReference type="PubMed" id="9426128"/>
<dbReference type="DOI" id="10.1046/j.1365-2958.1997.6242005.x"/>
</citation>
<scope>IDENTIFICATION AND DISCUSSION OF GYRA-BOX</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="J. Mol. Biol." volume="318" first="351" last="359">
<title>Identification of four GyrA residues involved in the DNA breakage-reunion reaction of DNA gyrase.</title>
<authorList>
<person name="Hockings S.C."/>
<person name="Maxwell A."/>
</authorList>
<dbReference type="PubMed" id="12051842"/>
<dbReference type="DOI" id="10.1016/S0022-2836(02)00048-7"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF ARG-32; ARG-47; HIS-78 AND HIS-80</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="3738" last="3742">
<title>The 'GyrA-box' is required for the ability of DNA gyrase to wrap DNA and catalyze the supercoiling reaction.</title>
<authorList>
<person name="Kramlinger V.M."/>
<person name="Hiasa H."/>
</authorList>
<dbReference type="PubMed" id="16332690"/>
<dbReference type="DOI" id="10.1074/jbc.M511160200"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 560-GLN--GLY-566</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Bacteriol." volume="189" first="5839" last="5849">
<title>Growth rate toxicity phenotypes and homeostatic supercoil control differentiate Escherichia coli from Salmonella enterica serovar Typhimurium.</title>
<authorList>
<person name="Champion K."/>
<person name="Higgins N.P."/>
</authorList>
<dbReference type="PubMed" id="17400739"/>
<dbReference type="DOI" id="10.1128/JB.00083-07"/>
</citation>
<scope>FUNCTION</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="8538" last="8545">
<title>DNA gyrase requires DNA for effective two-site coordination of divalent metal ions: further insight into the mechanism of enzyme action.</title>
<authorList>
<person name="Sissi C."/>
<person name="Chemello A."/>
<person name="Vazquez E."/>
<person name="Mitchenall L.A."/>
<person name="Maxwell A."/>
<person name="Palumbo M."/>
</authorList>
<dbReference type="PubMed" id="18642932"/>
<dbReference type="DOI" id="10.1021/bi800480j"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="J. Bacteriol." volume="191" first="1587" last="1594">
<title>The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex.</title>
<authorList>
<person name="Merens A."/>
<person name="Matrat S."/>
<person name="Aubry A."/>
<person name="Lascols C."/>
<person name="Jarlier V."/>
<person name="Soussy C.J."/>
<person name="Cavallo J.D."/>
<person name="Cambau E."/>
</authorList>
<dbReference type="PubMed" id="19060136"/>
<dbReference type="DOI" id="10.1128/JB.01205-08"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem. Lett." volume="20" first="2828" last="2831">
<title>Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.</title>
<authorList>
<person name="Ronkin S.M."/>
<person name="Badia M."/>
<person name="Bellon S."/>
<person name="Grillot A.L."/>
<person name="Gross C.H."/>
<person name="Grossman T.H."/>
<person name="Mani N."/>
<person name="Parsons J.D."/>
<person name="Stamos D."/>
<person name="Trudeau M."/>
<person name="Wei Y."/>
<person name="Charifson P.S."/>
</authorList>
<dbReference type="PubMed" id="20356737"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2010.03.052"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="18636" last="18644">
<title>Mechanisms for defining supercoiling set point of DNA gyrase orthologs: I. A nonconserved acidic C-terminal tail modulates Escherichia coli gyrase activity.</title>
<authorList>
<person name="Tretter E.M."/>
<person name="Berger J.M."/>
</authorList>
<dbReference type="PubMed" id="22457353"/>
<dbReference type="DOI" id="10.1074/jbc.M112.345678"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF 842-PRO--ALA-856 AND 854-SER--GLU-875</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="18645" last="18654">
<title>Mechanisms for defining supercoiling set point of DNA gyrase orthologs: II. The shape of the GyrA subunit C-terminal domain (CTD) is not a sole determinant for controlling supercoiling efficiency.</title>
<authorList>
<person name="Tretter E.M."/>
<person name="Berger J.M."/>
</authorList>
<dbReference type="PubMed" id="22457352"/>
<dbReference type="DOI" id="10.1074/jbc.M112.345736"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF 842-PRO--ALA-856</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="Bioorg. Med. Chem. Lett." volume="23" first="1537" last="1543">
<title>Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: development of inhibitors with broad spectrum, Gram-negative antibacterial activity.</title>
<authorList>
<person name="Trzoss M."/>
<person name="Bensen D.C."/>
<person name="Li X."/>
<person name="Chen Z."/>
<person name="Lam T."/>
<person name="Zhang J."/>
<person name="Creighton C.J."/>
<person name="Cunningham M.L."/>
<person name="Kwan B."/>
<person name="Stidham M."/>
<person name="Nelson K."/>
<person name="Brown-Driver V."/>
<person name="Castellano A."/>
<person name="Shaw K.J."/>
<person name="Lightstone F.C."/>
<person name="Wong S.E."/>
<person name="Nguyen T.B."/>
<person name="Finn J."/>
<person name="Tari L.W."/>
</authorList>
<dbReference type="PubMed" id="23294697"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2012.11.073"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="Nature" volume="388" first="903" last="906">
<title>Crystal structure of the breakage-reunion domain of DNA gyrase.</title>
<authorList>
<person name="Morais Cabral J.H."/>
<person name="Jackson A.P."/>
<person name="Smith C.V."/>
<person name="Shikotra N."/>
<person name="Maxwell A."/>
<person name="Liddington R.C."/>
</authorList>
<dbReference type="PubMed" id="9278055"/>
<dbReference type="DOI" id="10.1038/42294"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 30-522</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="J. Mol. Biol." volume="348" first="1091" last="1102">
<title>Molecular basis of gyrase poisoning by the addiction toxin CcdB.</title>
<authorList>
<person name="Dao-Thi M.H."/>
<person name="Van Melderen L."/>
<person name="De Genst E."/>
<person name="Afif H."/>
<person name="Buts L."/>
<person name="Wyns L."/>
<person name="Loris R."/>
</authorList>
<dbReference type="PubMed" id="15854646"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.03.049"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 363-494 IN COMPLEX WITH CCBD</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="26177" last="26184">
<title>A superhelical spiral in the Escherichia coli DNA gyrase A C-terminal domain imparts unidirectional supercoiling bias.</title>
<authorList>
<person name="Ruthenburg A.J."/>
<person name="Graybosch D.M."/>
<person name="Huetsch J.C."/>
<person name="Verdine G.L."/>
</authorList>
<dbReference type="PubMed" id="15897198"/>
<dbReference type="DOI" id="10.1074/jbc.M502838200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 535-841</scope>
<scope>DOMAIN</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Science" volume="326" first="1415" last="1418">
<title>A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase.</title>
<authorList>
<person name="Edwards M.J."/>
<person name="Flatman R.H."/>
<person name="Mitchenall L.A."/>
<person name="Stevenson C.E."/>
<person name="Le T.B."/>
<person name="Clarke T.A."/>
<person name="McKay A.R."/>
<person name="Fiedler H.P."/>
<person name="Buttner M.J."/>
<person name="Lawson D.M."/>
<person name="Maxwell A."/>
</authorList>
<dbReference type="PubMed" id="19965760"/>
<dbReference type="DOI" id="10.1126/science.1179123"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.62 ANGSTROMS) OF 1-525 IN COMPLEX WITH ANTIBIOTIC</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="5 9 10 13 14 15 16 17 19 20 21 25 26 27 30 31 33">A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to maintain chromosomes in an underwound state (PubMed:3031051, PubMed:186775, PubMed:7811004, PubMed:9148951, PubMed:12051842, PubMed:18642932, PubMed:19060136, PubMed:20356737, PubMed:22457353, PubMed:23294697, PubMed:19965760). This makes better substrates for topoisomerase IV (ParC and ParE) which is the main enzyme that unlinks newly replicated chromosomes in E.coli (PubMed:9334322). Gyrase catalyzes the interconversion of other topological isomers of dsDNA rings, including catenanes (PubMed:22457352). Relaxes negatively supercoiled DNA in an ATP-independent manner (PubMed:337300). E.coli gyrase has higher supercoiling activity than many other bacterial gyrases; at comparable concentrations E.coli gyrase introduces more supercoils faster than M.tuberculosis gyrase, while M.tuberculosis gyrase has higher decatenation than supercoiling activity compared to E.coli (PubMed:22457352). E.coli makes 15% more negative supercoils in pBR322 plasmid DNA than S.typhimurium; the S.typhimurium GyrB subunit is toxic in E.coli, while the E.coli copy can be expressed in S.typhimurium even though the 2 subunits have 777/804 residues identical (PubMed:17400739). The enzymatic differences between E.coli gyrase and topoisomerase IV are largely due to the GyrA C-terminal domain (approximately residues 524-841) and specifically the GyrA-box (PubMed:8962066, PubMed:16332690).</text>
</comment>
<comment type="function">
<text>Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Type II topoisomerases break and join 2 DNA strands simultaneously in an ATP-dependent manner.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4 5 13 14 16 32">
<text>ATP-dependent breakage, passage and rejoining of double-stranded DNA.</text>
<dbReference type="EC" id="5.6.2.3"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="15 17 21 26 27 31">Gyrase is the target of many classes of inhibitors, including coumarins, cyclothialidines, pyrrolopyrimidines, pyrazolthiazoles and (fluoro)quinolones. Quinolones bind GyrA when the enzyme is complexed with DNA and trap the enzyme in a covalent reaction intermediate with DNA (PubMed:3031051, PubMed:12051842). Coumarins bind to GyrB and are competitive inhibitors of its ATPase activity (PubMed:7811004). Cyclothialidines also bind GyrB and are ATPase competitive inhibitors; they seem to act differently from coumarins (PubMed:7811004). Pyrrolopyrimidines inhibit both GyrB and its paralog in topoisomerase IV (parE) (PubMed:23294697). Pyrazolthiazoles also inhibit the ATPase activity of GyrB (PubMed:20356737). DNA supercoiling and relaxation are both inhibited by oxolinic acid (PubMed:337300). Acriflavine inhibits supercoiling activity and DNA-stimulated ATPase activity (PubMed:9148951). DNA supercoiling activity is protected from fluoroquinolone inhibition by QnrB4; QnrB4 has no effect on supercoiling activity alone (PubMed:19060136).</text>
</comment>
<comment type="subunit">
<text evidence="5 6 7 13 16 28 29 31">Heterotetramer, composed of two GyrA and two GyrB chains (PubMed:9148951, PubMed:12051842). In the heterotetramer, GyrA contains the active site tyrosine that forms a transient covalent intermediate with the DNA, while GyrB binds cofactors and catalyzes ATP hydrolysis (PubMed:12051842, PubMed:18642932, PubMed:19965760, PubMed:9148951). Can form a 2:2 complex with toxin CcdB in which GyrA is inactive; rejuvenation of GyrA(2)CcdB(2) is effected by CcdA (PubMed:15854646, PubMed:1324324, PubMed:8254658, PubMed:8604132).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-547129"/>
<interactant intactId="EBI-547129"/>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-547129"/>
<interactant intactId="EBI-541911">
<id>P0AES6</id>
<label>gyrB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="domain">
<text evidence="30">An N-terminal fragment (residues 1-523) can be reconstituted with GyrB, but the complex no longer has negative supercoiling or ATP-independent DNA relaxation activities, although it is capable of DNA cleavage; ATP-dependent relaxation is inhibited by novobiocin and non-hydrolyzable ATP analogs (PubMed:8962066). The fragment has ATP-dependent DNA relaxation and 30-fold improved decatenation activities, unlike holoenzyme it preferentially binds supercoiled DNA (PubMed:8962066). This N-terminal fragment becomes a topoisomerase IV-like enzyme; it poorly complements a temperature-sensitive parC mutation (parC is the topoisomerase IV paralog of gyrA) (PubMed:8962066).</text>
</comment>
<comment type="domain">
<text evidence="8 9 20 39">The C-terminal domain (CTD, approximately residues 535-841) contains 6 tandemly repeated subdomains known as blades, each of which is composed of a 4-stranded antiparallel beta-sheet (PubMed:15897198). The blades form a circular-shaped beta-pinwheel fold arranged in a spiral around a screw axis, to which DNA probably binds, inducing strong positive superhelicity (about 0.8 links/protein) (PubMed:15897198). The non-conserved, C-terminal acidic tail (residues 842-875) regulates wrapping and DNA-binding by the CTD; deletions within the tail show it is autoinhibitory for DNA wrapping and binding, and couples ATP hydrolysis to DNA strand passage (PubMed:22457353). The GyrA-box is a 7 amino acid motif found in the first blade of the CTD which is discriminative for gyrase versus topoisomerase IV activity (PubMed:9426128). The GyrA-box is required for wrapping of DNA around gyrase, and thus is essential for the DNA supercoiling activity but not DNA relaxation or decatenation activities of gyrase (PubMed:16332690).</text>
</comment>
<comment type="miscellaneous">
<text evidence="6 25 28 38">When the enzyme transiently cleaves DNA a phosphotyrosine bond is formed between GyrA and DNA (PubMed:3031051). In the presence of quinolones this intermediate can be trapped and is used as an indicator of drug toxicity (PubMed:12051842). The enzyme-DNA intermediate is also the target of a number of topoisomerase poisons, including toxin CcdB (PubMed:1324324, PubMed:8254658).</text>
</comment>
<comment type="miscellaneous">
<text evidence="4 10 19">Few gyrases are as efficient as E.coli at forming negative supercoils (PubMed:22457352, PubMed:17400739). Not all organisms have 2 type II topoisomerases; in organisms with a single type II topoisomerase this enzyme also has to decatenate newly replicated chromosomes.</text>
</comment>
<comment type="similarity">
<text evidence="4">Belongs to the type II topoisomerase GyrA/ParC subunit family.</text>
</comment>
<dbReference type="EC" id="5.6.2.3" evidence="4 5 13 14 16 32"/>
<dbReference type="EMBL" id="X06373">
<property type="protein sequence ID" value="CAA29676.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06744">
<property type="protein sequence ID" value="CAA29919.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M15631">
<property type="protein sequence ID" value="AAA23948.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U00096">
<property type="protein sequence ID" value="AAC75291.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP009048">
<property type="protein sequence ID" value="BAA16048.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y00544">
<property type="protein sequence ID" value="CAA68611.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="PIR" id="S02340">
<property type="entry name" value="ITECAP"/>
</dbReference>
<dbReference type="RefSeq" id="NP_416734.1">
<property type="nucleotide sequence ID" value="NC_000913.3"/>
</dbReference>
<dbReference type="RefSeq" id="WP_001281242.1">
<property type="nucleotide sequence ID" value="NZ_LN832404.1"/>
</dbReference>
<dbReference type="PDB" id="1AB4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=30-522"/>
</dbReference>
<dbReference type="PDB" id="1X75">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=363-494"/>
</dbReference>
<dbReference type="PDB" id="1ZI0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=535-841"/>
</dbReference>
<dbReference type="PDB" id="2Y3P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A/B=2-523"/>
</dbReference>
<dbReference type="PDB" id="3NUH">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=1-525"/>
</dbReference>
<dbReference type="PDB" id="4ELY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="A/B=363-497"/>
</dbReference>
<dbReference type="PDBsum" id="1AB4"/>
<dbReference type="PDBsum" id="1X75"/>
<dbReference type="PDBsum" id="1ZI0"/>
<dbReference type="PDBsum" id="2Y3P"/>
<dbReference type="PDBsum" id="3NUH"/>
<dbReference type="PDBsum" id="4ELY"/>
<dbReference type="SMR" id="P0AES4"/>
<dbReference type="BioGrid" id="4262132">
<property type="interactions" value="294"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2177">
<property type="entry name" value="GyrA-GyrB complex"/>
</dbReference>
<dbReference type="DIP" id="DIP-36179N"/>
<dbReference type="IntAct" id="P0AES4">
<property type="interactions" value="53"/>
</dbReference>
<dbReference type="MINT" id="P0AES4"/>
<dbReference type="STRING" id="511145.b2231"/>
<dbReference type="BindingDB" id="P0AES4"/>
<dbReference type="ChEMBL" id="CHEMBL1858"/>
<dbReference type="DrugBank" id="DB00537">
<property type="generic name" value="Ciprofloxacin"/>
</dbReference>
<dbReference type="SWISS-2DPAGE" id="P0AES4"/>
<dbReference type="EPD" id="P0AES4"/>
<dbReference type="jPOST" id="P0AES4"/>
<dbReference type="PaxDb" id="P0AES4"/>
<dbReference type="PRIDE" id="P0AES4"/>
<dbReference type="EnsemblBacteria" id="AAC75291">
<property type="protein sequence ID" value="AAC75291"/>
<property type="gene ID" value="b2231"/>
</dbReference>
<dbReference type="EnsemblBacteria" id="BAA16048">
<property type="protein sequence ID" value="BAA16048"/>
<property type="gene ID" value="BAA16048"/>
</dbReference>
<dbReference type="GeneID" id="946614"/>
<dbReference type="KEGG" id="ecj:JW2225"/>
<dbReference type="KEGG" id="eco:b2231"/>
<dbReference type="PATRIC" id="fig|1411691.4.peg.4"/>
<dbReference type="EchoBASE" id="EB0418"/>
<dbReference type="EcoGene" id="EG10423">
<property type="gene designation" value="gyrA"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4105C24">
<property type="taxonomic scope" value="Bacteria"/>
</dbReference>
<dbReference type="eggNOG" id="COG0188">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000076278"/>
<dbReference type="InParanoid" id="P0AES4"/>
<dbReference type="KO" id="K02469"/>
<dbReference type="PhylomeDB" id="P0AES4"/>
<dbReference type="BioCyc" id="EcoCyc:EG10423-MONOMER"/>
<dbReference type="BioCyc" id="ECOL316407:JW2225-MONOMER"/>
<dbReference type="BioCyc" id="MetaCyc:EG10423-MONOMER"/>
<dbReference type="EvolutionaryTrace" id="P0AES4"/>
<dbReference type="PRO" id="PR:P0AES4"/>
<dbReference type="Proteomes" id="UP000000318">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="Proteomes" id="UP000000625">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoliWiki"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniRule"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoliWiki"/>
</dbReference>
<dbReference type="GO" id="GO:0034335">
<property type="term" value="F:DNA supercoiling activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003918">
<property type="term" value="F:DNA topoisomerase type II (ATP-hydrolyzing) activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0008094">
<property type="term" value="F:DNA-dependent ATPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoliWiki"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0006265">
<property type="term" value="P:DNA topological change"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="EcoliWiki"/>
</dbReference>
<dbReference type="GO" id="GO:0006261">
<property type="term" value="P:DNA-dependent DNA replication"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniRule"/>
</dbReference>
<dbReference type="GO" id="GO:0046677">
<property type="term" value="P:response to antibiotic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="EcoliWiki"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoliWiki"/>
</dbReference>
<dbReference type="CDD" id="cd00187">
<property type="entry name" value="TOP4c"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.268.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.120.10.90">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.199.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_01897">
<property type="entry name" value="GyrA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR005743">
<property type="entry name" value="GyrA"/>
</dbReference>
<dbReference type="InterPro" id="IPR006691">
<property type="entry name" value="GyrA/parC_rep"/>
</dbReference>
<dbReference type="InterPro" id="IPR035516">
<property type="entry name" value="Gyrase/topoIV_suA_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR013760">
<property type="entry name" value="Topo_IIA-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002205">
<property type="entry name" value="Topo_IIA_A/C"/>
</dbReference>
<dbReference type="InterPro" id="IPR013758">
<property type="entry name" value="Topo_IIA_A/C_ab"/>
</dbReference>
<dbReference type="InterPro" id="IPR013757">
<property type="entry name" value="Topo_IIA_A_a_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF03989">
<property type="entry name" value="DNA_gyraseA_C"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="Pfam" id="PF00521">
<property type="entry name" value="DNA_topoisoIV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00434">
<property type="entry name" value="TOP4c"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF101904">
<property type="entry name" value="SSF101904"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56719">
<property type="entry name" value="SSF56719"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0046">Antibiotic resistance</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0413">Isomerase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0799">Topoisomerase</keyword>
<feature type="initiator methionine" description="Removed" evidence="24">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="DNA gyrase subunit A" id="PRO_0000145232">
<location>
<begin position="2"/>
<end position="875"/>
</location>
</feature>
<feature type="region of interest" description="C-terminal domain (CTD)" evidence="34">
<location>
<begin position="531"/>
<end position="841"/>
</location>
</feature>
<feature type="region of interest" description="Acidic tail" evidence="35">
<location>
<begin position="842"/>
<end position="875"/>
</location>
</feature>
<feature type="short sequence motif" description="GyrA-box" evidence="4 37">
<location>
<begin position="560"/>
<end position="566"/>
</location>
</feature>
<feature type="active site" description="O-(5'-phospho-DNA)-tyrosine intermediate" evidence="4 25">
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In PPA-10; quinolone-resistant." evidence="18">
<original>A</original>
<variation>S</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In NAL-97; quinolone-resistant." evidence="18">
<original>G</original>
<variation>C</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In NAL-51, NAL-112, NAL-118, NAL-119 and strains 58, 158, 218, 231 and 235; quinolone-resistant." evidence="12 18">
<original>S</original>
<variation>L</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In PPA-18 and strains 233 and 227; quinolone-resistant." evidence="12 18 22">
<original>S</original>
<variation>W</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In PPA-05; quinolone-resistant." evidence="18">
<original>A</original>
<variation>P</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In NAL-113 and OV6; quinolone-resistant." evidence="18 23">
<original>D</original>
<variation>N</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 202; partially quinolone-resistant." evidence="12">
<original>D</original>
<variation>V</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In NAL-89; quinolone-resistant." evidence="18">
<original>Q</original>
<variation>H</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 227." evidence="22">
<original>D</original>
<variation>E</variation>
<location>
<position position="678"/>
</location>
</feature>
<feature type="sequence variant" description="In strain OV6; quinolone-resistant." evidence="23">
<original>I</original>
<variation>IMMI</variation>
<location>
<position position="798"/>
</location>
</feature>
<feature type="sequence variant" description="In strain: 227." evidence="22">
<original>A</original>
<variation>S</variation>
<location>
<position position="828"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes DNA supercoiling. Reduces quinolone-induced DNA cleavage and relaxation." evidence="5">
<original>R</original>
<variation>A</variation>
<variation>Q</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes DNA supercoiling. Reduces quinolone-induced DNA cleavage. Slightly reduces DNA relaxation." evidence="5">
<original>R</original>
<variation>Q</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolishes DNA supercoiling. Reduces quinolone-induced DNA cleavage and DNA relaxation." evidence="5">
<original>H</original>
<variation>A</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces DNA supercoiling. Slightly reduces quinolone-induced DNA cleavage. No effect on DNA relaxation." evidence="5">
<original>H</original>
<variation>A</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="mutagenesis site" description="Resistant to fluoroquinolones." evidence="11">
<original>S</original>
<variation>A</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="mutagenesis site" description="Resistant to fluoroquinolones." evidence="11">
<original>Q</original>
<variation>R</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="mutagenesis site" description="In gyrA462; resistant to cytotoxic protein CcdB, but not to the quinoline antibiotic enoxacin, has no effect on DNA supercoiling. Does not interact with CcdB." evidence="6 28">
<original>R</original>
<variation>C</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of gyrase-mediated DNA wrapping, nearly complete loss of DNA supercoiling activity, no change in DNA supercoil relaxation or DNA decatenation activity." evidence="9">
<original>QRRGGKG</original>
<variation>AAAAAAA</variation>
<location>
<begin position="560"/>
<end position="566"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of gyrase-mediated DNA wrapping, nearly complete loss of DNA supercoiling activity, no change in DNA supercoil relaxation or DNA decatenation activity." evidence="9">
<location>
<begin position="560"/>
<end position="566"/>
</location>
</feature>
<feature type="mutagenesis site" description="Gains ability to wrap DNA around itself in the absence of GyrB; holoenzyme gains ability to wrap DNA in the absence of ATP analogs, but reduces ATP-dependent supercoiling activity 50-fold, DNA is not as extensively negatively supercoiled, has 10-fold less ATP-independent negative supercoiled DNA relaxation activity, no change in ATPase activity of holoenzyme, no change in decatenation ability. Isolated CTD gains ability to wrap DNA around itself in the absence of GyrB, binds DNA better than wild-type CTD." evidence="19 20">
<location>
<begin position="842"/>
<end position="856"/>
</location>
</feature>
<feature type="mutagenesis site" description="Isolated CTD gains ability to wrap DNA around itself in the absence of GyrB, binds DNA better than wild-type CTD." evidence="20">
<location>
<begin position="854"/>
<end position="875"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="31"/>
<end position="33"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="43"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="59"/>
<end position="61"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="66"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="82"/>
<end position="91"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="102"/>
<end position="107"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="120"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="131"/>
<end position="134"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="136"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="145"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="151"/>
<end position="158"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="165"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="187"/>
<end position="199"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="205"/>
<end position="208"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="227"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="236"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="245"/>
<end position="249"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="258"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="270"/>
<end position="281"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="292"/>
<end position="294"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="314"/>
<end position="323"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="327"/>
<end position="333"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="335"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="341"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="347"/>
<end position="388"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="390"/>
<end position="399"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="400"/>
<end position="402"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="403"/>
<end position="412"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="441"/>
<end position="449"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="452"/>
<end position="459"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="463"/>
<end position="466"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="468"/>
<end position="493"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="495"/>
<end position="513"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="519"/>
<end position="521"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="538"/>
<end position="544"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="547"/>
<end position="553"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="556"/>
<end position="560"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="578"/>
<end position="585"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="589"/>
<end position="594"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="597"/>
<end position="603"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="604"/>
<end position="606"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="612"/>
<end position="614"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="619"/>
<end position="621"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="631"/>
<end position="638"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="645"/>
<end position="650"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="653"/>
<end position="659"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="660"/>
<end position="663"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="671"/>
<end position="674"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="682"/>
<end position="688"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="693"/>
<end position="698"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="701"/>
<end position="707"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="708"/>
<end position="710"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="732"/>
<end position="736"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="743"/>
<end position="748"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="751"/>
<end position="756"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="758"/>
<end position="760"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="771"/>
<end position="774"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="778"/>
<end position="780"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="782"/>
<end position="789"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="794"/>
<end position="801"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="804"/>
<end position="808"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="809"/>
<end position="811"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="833"/>
<end position="838"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1AB4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1X75"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZI0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="HAMAP-Rule" id="MF_01897"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12051842"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1324324"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15854646"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15897198"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16332690"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17400739"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1850970"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1850972"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18642932"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="186775"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19060136"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19965760"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20356737"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2168148"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22457352"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22457353"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23294697"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2548439"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2834621"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3029031"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3031051"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="337300"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7811004"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8254658"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8604132"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8962066"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9148951"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9278055"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9334322"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15897198"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="22457353"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="337300"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9426128"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12051842"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9426128"/>
</source>
</evidence>
<sequence length="875" mass="96964" checksum="3FD5BD52A5969069" modified="2005-12-20" version="1">
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNV
AAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVV
VTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVY
SMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVL
TEFNRLRTAGKVAIKLVDGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTG
VRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERN
GLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>